NCT04040218 is a NA clinical trial of Dry Needling in Dry Needling, sponsored by Regis University.

Who is sponsoring NCT04040218?

NCT04040218 is sponsored by Regis University.

What drugs are being tested in NCT04040218?

Interventions in NCT04040218: Dry Needling.

What condition does NCT04040218 study?

NCT04040218 studies Dry Needling, Harm.

Is NCT04040218 still recruiting?

NCT04040218 is currently completed. Last updated 31 July 2019.

Last reviewed 2019-07-31 · How we verify

NCT04040218

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient

Completed NA Last updated 31 July 2019

What this trial tests

NA trial testing Dry Needling in Dry Needling in 2,607 participants. Completed in 30 April 2017.

Timeline

1 April 2017

Primary endpoint
30 April 2017

30 April 2017

Quick facts

Lead sponsor	Regis University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	2,607
Start date	1 April 2017
Primary completion	30 April 2017
Estimated completion	30 April 2017
Sites	1 location across United States

Drugs / interventions tested

Dry Needling

Conditions studied

Dry Needling — all drugs for Dry Needling →
Harm — all drugs for Harm →

Sponsor

Regis University

Who can join

18 and older, any sex, with Dry Needling or Harm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective analysis of responses following a descriptive survey to investigate the benefits and harms associated with dry needling as provided by a physical therapists in CO

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
NCT07456735 — Comparison of the Effectiveness of Dry Needling Versus the Combination of Dry Needling and Local Anesthetic Injection in · Phase 4 · not yet recruiting
NCT07270276 — The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain · NA · recruiting
NCT07133139 — Treatment Validation for Myofascial Pain · NA · recruiting
NCT07190768 — Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome · NA · not yet recruiting

Other recruiting trials for Dry Needling

Currently open trials in the same condition.

NCT06845969 — Physiotherapy Dry Needling Accuracy · NA · recruiting
NCT06705634 — How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation · NA · active not recruiting
NCT05596240 — Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain · NA · active not recruiting

Other Regis University trials

Trials by the same sponsor.

NCT05015088 — Effectiveness of Gastrocnemius Stretching · completed
NCT04487327 — The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional Outcomes in Individuals With Inju · NA · completed
NCT03689283 — The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Trigger Points · NA · completed
NCT04223245 — A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease · NA · completed
NCT04164303 — Conservative Management of DeQuervain's Tendinopathy With an Orthopaedic Manual Therapy Approach Emphasizing First CMC M · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04040218 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Regis University
Last refreshed: 31 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04040218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing